GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NetraMark Holdings Inc (OTCPK:AINMF) » Definitions » EBITDA Margin %

AINMF (NetraMark Holdings) EBITDA Margin % : -733.33% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is NetraMark Holdings EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. NetraMark Holdings's EBITDA for the three months ended in Jun. 2024 was $-0.66 Mil. NetraMark Holdings's Revenue for the three months ended in Jun. 2024 was $0.09 Mil. Therefore, NetraMark Holdings's EBITDA margin for the quarter that ended in Jun. 2024 was -733.33%.


NetraMark Holdings EBITDA Margin % Historical Data

The historical data trend for NetraMark Holdings's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NetraMark Holdings EBITDA Margin % Chart

NetraMark Holdings Annual Data
Trend Sep20 Sep21 Sep22 Sep23
EBITDA Margin %
- - -6,469.41 -6,000.00

NetraMark Holdings Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -322.56 -733.33

Competitive Comparison of NetraMark Holdings's EBITDA Margin %

For the Health Information Services subindustry, NetraMark Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NetraMark Holdings's EBITDA Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NetraMark Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where NetraMark Holdings's EBITDA Margin % falls into.



NetraMark Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

NetraMark Holdings's EBITDA Margin % for the fiscal year that ended in Sep. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Sep. 2023 )/Revenue (A: Sep. 2023 )
=-3.96/0.066
=-6,000.00 %

NetraMark Holdings's EBITDA Margin % for the quarter that ended in Jun. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-0.66/0.09
=-733.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NetraMark Holdings  (OTCPK:AINMF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


NetraMark Holdings EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of NetraMark Holdings's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


NetraMark Holdings Business Description

Traded in Other Exchanges
Address
1655 Dupont Street, Suite 101, Toronto, ON, CAN, M6P 3T1
NetraMark Holdings Inc is focused on the application of an Artificial Intelligence (AI) / Machine Learning (ML) solution targeted at the pharmaceutical industry in order to de-risk clinical trials. NetraMark has a proprietary technology that is capable of cutting through the combinatorial complexity that comes with dealing with heterogeneous patient populations to extract precisely defined personas of patients with respect to placebo and drug response, in addition to tolerability and adverse events. By using the client's own contemporaneous data, and having the capacity to learn from small data, the NetraAI tech extracts these personas to equip pharmaceutical companies with strategies to optimize their next trials for success.